KLIFO is a leading drug development consultancy headquartered in Copenhagen with extensive experience in partnering with biotech and pharmaceutical companies to advance their drug development projects. The company is a leader in the Scandinavian market and has operations in Germany and the Netherlands.

The business offers multi-disciplinary consulting and operational solutions spanning all areas of clinical research, including drug development consultancy, regulatory affairs, clinical operations, quality assurance, and clinical trial supply. KLIFO enables faster and cheaper development of new, innovative, and personalized medicines, to facilitate the increasing and evolving market for new drugs and healthcare in general. This enables the firm to contribute to the lowering of costs in healthcare.

Following Gilde Healthcare’s acquisition in 2021, KLIFO aims to grow and deepen its offering and geographic presence organically and through an active buy-and-build strategy.